Marion Dorsch
President bij Atavistik Bio, Inc.
Actieve functies van Marion Dorsch
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Atavistik Bio, Inc.
Atavistik Bio, Inc. BiotechnologyHealth Technology Atavistik Bio, Inc. is a pre-clinical stage biotechnology company located in an undisclosed location. The American company is pioneering a synthetic, scalable approach to identify and harness highly conserved protein-metabolite interactions to revolutionize small molecule drug discovery. The company's advanced data analytics and AI platforms leverage structure-based drug design to engineer novel, highly specific small molecule drugs to activate, inhibit or stabilize targets. The company is led by an experienced management team and advisors, plus a robust investment syndicate, and is positioned to deliver transformational science to ultimately improve patient care. Atavistik Bio was founded by prominent scientists who are considered among the leading authorities in cell biology, cancer cell biology and cell metabolism. Bryan E Stuart has been the CEO of the company since 2023. | Chief Tech/Sci/R&D Officer | 01-04-2021 | - |
President | 01-04-2021 | - |
Loopbaan van Marion Dorsch
Eerdere bekende functies van Marion Dorsch
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
BLUEPRINT MEDICINES CORPORATION | Chief Tech/Sci/R&D Officer | 21-11-2016 | 01-03-2021 |
AGIOS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-04-2012 | 01-11-2016 |
Sanofi-Aventis France SA
Sanofi-Aventis France SA Medical DistributorsDistribution Services Sanofi-Aventis France engages in wholesale of pharmaceutical products. The company is headquartered in Gentilly, France. | Corporate Officer/Principal | 01-01-2010 | 01-04-2012 |
Opleiding van Marion Dorsch
Freie Universität Berlin | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 4 |
Duitsland | 2 |
Frankrijk | 2 |
Operationeel
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 2 |
Distribution Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
AGIOS PHARMACEUTICALS, INC. | Health Technology |
BLUEPRINT MEDICINES CORPORATION | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Sanofi-Aventis France SA
Sanofi-Aventis France SA Medical DistributorsDistribution Services Sanofi-Aventis France engages in wholesale of pharmaceutical products. The company is headquartered in Gentilly, France. | Distribution Services |
Atavistik Bio, Inc.
Atavistik Bio, Inc. BiotechnologyHealth Technology Atavistik Bio, Inc. is a pre-clinical stage biotechnology company located in an undisclosed location. The American company is pioneering a synthetic, scalable approach to identify and harness highly conserved protein-metabolite interactions to revolutionize small molecule drug discovery. The company's advanced data analytics and AI platforms leverage structure-based drug design to engineer novel, highly specific small molecule drugs to activate, inhibit or stabilize targets. The company is led by an experienced management team and advisors, plus a robust investment syndicate, and is positioned to deliver transformational science to ultimately improve patient care. Atavistik Bio was founded by prominent scientists who are considered among the leading authorities in cell biology, cancer cell biology and cell metabolism. Bryan E Stuart has been the CEO of the company since 2023. | Health Technology |
- Beurs
- Insiders
- Marion Dorsch
- Ervaring